Kaya Ltd
- Market Cap ₹ 461 Cr.
- Current Price ₹ 352
- High / Low ₹ 399 / 303
- Stock P/E
- Book Value ₹ -94.9
- Dividend Yield 0.00 %
- ROCE -43.5 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -1.21% over past five years.
- Earnings include an other income of Rs.7.26 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
332 | 370 | 409 | 400 | 421 | 393 | 275 | 324 | 377 | 401 | |
296 | 352 | 425 | 399 | 408 | 338 | 248 | 305 | 395 | 389 | |
Operating Profit | 37 | 18 | -16 | 1 | 13 | 56 | 27 | 19 | -19 | 12 |
OPM % | 11% | 5% | -4% | 0% | 3% | 14% | 10% | 6% | -5% | 3% |
11 | 12 | 10 | 9 | 4 | 9 | 15 | 12 | 5 | 7 | |
Interest | 4 | 4 | 5 | 7 | 9 | 22 | 19 | 21 | 42 | 43 |
Depreciation | 12 | 17 | 20 | 24 | 29 | 75 | 60 | 78 | 61 | 63 |
Profit before tax | 32 | 9 | -31 | -20 | -21 | -33 | -37 | -68 | -116 | -87 |
Tax % | 0% | 0% | 8% | 2% | 26% | -64% | 0% | 0% | 0% | |
32 | 9 | -28 | -20 | -16 | -54 | -37 | -68 | -116 | -87 | |
EPS in Rs | 6.82 | -22.23 | -16.22 | -12.22 | -41.66 | -29.10 | -52.69 | -89.15 | -66.13 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | -1% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -12% |
3 Years: | 14% |
1 Year: | 12% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Reserves | 222 | 238 | 216 | 197 | 145 | 69 | 41 | -15 | -117 | -137 |
0 | 0 | 30 | 25 | 35 | 167 | 160 | 204 | 249 | 271 | |
151 | 155 | 187 | 136 | 176 | 160 | 153 | 159 | 225 | 216 | |
Total Liabilities | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 363 |
112 | 149 | 193 | 201 | 206 | 303 | 279 | 240 | 217 | 242 | |
CWIP | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 0 |
Investments | 152 | 88 | 72 | 20 | 14 | 19 | 11 | 26 | 21 | 22 |
105 | 167 | 179 | 149 | 147 | 86 | 77 | 93 | 130 | 99 | |
Total Assets | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 363 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
29 | 5 | -8 | -12 | 22 | 47 | 32 | 30 | 63 | |
-16 | -5 | -39 | 24 | -28 | -12 | 4 | -34 | -39 | |
-0 | -0 | 33 | -7 | 5 | -47 | -31 | 12 | -18 | |
Net Cash Flow | 13 | 0 | -13 | 5 | -1 | -11 | 5 | 8 | 5 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 1 | 2 | 3 | 5 | 5 | 4 | 4 | 3 |
Inventory Days | 419 | 492 | 493 | ||||||
Days Payable | 360 | 349 | 339 | ||||||
Cash Conversion Cycle | 60 | 144 | 156 | 3 | 5 | 5 | 4 | 4 | 3 |
Working Capital Days | -80 | -27 | -81 | -52 | -86 | -80 | -113 | -107 | -138 |
ROCE % | 2% | -12% | -7% | -6% | -5% | -8% | -23% | -44% |
Documents
Announcements
- Revised Proceedings Of AGM Held On July 27, 2023 With Conclusion Time 9 Apr
- Reg 7(3) - Compliance Certificate For Financial Year Ended March 31, 2024 8 Apr
- Submission Of Reconciliation Of Share Capital Audit Report For Quarter Ended March 31, 2024 Under Regulation 76 Of SEBI( DP) Regulations, 2018 8 Apr
-
Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulation, 2015
8 Apr - Compliance Certificate w.r.t Transfer or Transmission or Transposition of Securities for the financial year ended March 31, 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr
Annual reports
Concalls
-
Jan 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Nov 2022Transcript PPT REC
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Jan 2021TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jan 2020Transcript PPT
-
Oct 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018Transcript PPT
-
Oct 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Apr 2017TranscriptPPT
-
Feb 2017TranscriptPPT
-
Oct 2016TranscriptPPT
-
Aug 2016TranscriptPPT
-
May 2016TranscriptPPT
-
Jan 2016TranscriptPPT
-
Nov 2015TranscriptPPT
-
Aug 2015TranscriptPPT
Business Overview:[1]
KL started as a division of Marico Limited
and later emerged as a separate entity. Currently, the promoter group owns a 59.93% stake in Kaya. The company is engaged in providing skincare and hair care solutions through a range of clinics across India and the Middle East.